Search - tctmd.com

Displaying 961 - 980 of 1111

Sort: Relevancy | Date

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Daily News

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 09, 2012

News Features

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 07, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Industry News

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

April 25, 2012

News Industry News

OrbusNeich’s Genous™ Stent Achieves Complete Endothelialization at Two Weeks

April 20, 2012

News Daily News

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Jason Kahn

April 17, 2012

Presentation GI2 2012

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

Presenter: Fausto Feres

April 13, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Daily News

Baseline Anemia Raises Risk for Stent Thrombosis After DES

L.A. McKeown

April 04, 2012

News Daily News

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

April 03, 2012

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

Presentation

Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting

Presenter: Marco Valgimigli

April 02, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Industry News

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

March 27, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

Advertisement

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

Strong Showing for Bioabsorbable-Scaffold DES

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

OrbusNeich’s Genous™ Stent Achieves Complete Endothelialization at Two Weeks

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Dual Antiplatelet Therapy Post PCI: Challenging the Guidelines

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Baseline Anemia Raises Risk for Stent Thrombosis After DES

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

PRODIGY Published: No Advantage to Long-term Clopidogrel

Short- vs. Long-term Duration of Dual Antiplatelet Therapy (DAPT) After Coronary Stenting

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content